FDA clears Medtronic's Hugo surgical robot for general surgery
The clearance widens the robot's US use to upper and lower abdominal procedures.
A US regulator has approved a surgical robot for more common belly operations. A surgeon still guides the robot.
3.5MUS surgeries a year covered
Hype check
Hype4
Real4
The noise matches the real change.
Our editorial opinion, based on the sources below. How we score
Why it matters
It widens the range of operations US hospitals can perform with this robot.
For most people
Watch: nothing for you to do now.
The details
- Medtronic announced the FDA clearance of Hugo for general surgery in the week of 20 November 2026.
- Upper abdominal clearance covers cholecystectomy, Roux-en-Y gastric bypass, ventral hernia repair and small bowel resection.
- Lower abdominal clearance covers inguinal hernia repair and appendectomy.
- Medtronic says these procedures total about 3.5 million US surgeries a year.
- The company expects Hugo to pass 50,000 procedures worldwide by the end of its fiscal year.
- Hugo received CE marking for general surgery in Europe in 2022 and US approval for urology in December 2025.
WatchWatch: the clearance is US-only, and hospitals and surgeons decide how it is used.
Receipts
One trusted outlet reports it. Not confirmed yet. Open the sources and check us.
Written with the help of AI tools and checked against the sources above. How we work
See a mistake? Tell us and we’ll fix it.